PMID- 32694556 OWN - NLM STAT- MEDLINE DCOM- 20210324 LR - 20210721 IS - 2041-4889 (Electronic) VI - 11 IP - 7 DP - 2020 Jul 21 TI - CircRNA TADA2A relieves idiopathic pulmonary fibrosis by inhibiting proliferation and activation of fibroblasts. PG - 553 LID - 10.1038/s41419-020-02747-9 [doi] LID - 553 AB - The excessive activation and proliferation of lung fibroblasts are responsible for the abundant deposition of extracellular matrix (ECM) in idiopathic pulmonary fibrosis (IPF), while its specific mechanism is still unknown. This study focuses on the role of circRNA (circ) TADA2A in functional abnormalities of lung fibroblasts and aims to elaborate its regulatory mechanism. In the present study, circTADA2A was downregulated in both IPF primary human lung fibroblasts and human IPF fibroblastic cell lines. Functionally, the overexpression of circTADA2A repressed the activation and proliferation of normal human fibroblastic cell line induced by several fibrogenic growth factors. Using fluorescence in situ hybridization (FISH), luciferase reporter assays, and RNA pull-down, circTADA2A was confirmed to function as sponges of miR-526b and miR-203, thus releasing the expression of Caveolin (Cav)-1 and Cav2. The overexpression of circTADA2A suppressed lung-fibroblasts activation via Cav1 and reduced lung-fibroblasts proliferation via Cav2. In vivo experiments also confirmed that the overexpression of circTADA2A decreased fibrogenic responses induced by bleomycin in lung-fibrosis mice. Collectively, circTADA2A repressed lung-fibroblasts activation via miR-526b/Cav1 and reduced lung-fibroblasts proliferation via miR-203/Cav2, thus inhibiting the excessive deposition of ECM and relieving IPF. FAU - Li, Juan AU - Li J AD - Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China. FAU - Li, Ping AU - Li P AD - Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China. FAU - Zhang, Guojun AU - Zhang G AD - Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China. FAU - Qin, Pan AU - Qin P AD - Department of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China. FAU - Zhang, Da AU - Zhang D AD - Department of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China. FAU - Zhao, Wei AU - Zhao W AD - Department of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China. fcczhaow@zzu.edu.cn. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20200721 PL - England TA - Cell Death Dis JT - Cell death & disease JID - 101524092 RN - 0 (Caveolins) RN - 0 (Intercellular Signaling Peptides and Proteins) RN - 0 (MicroRNAs) RN - 0 (RNA, Circular) SB - IM MH - Adult MH - Aged MH - Animals MH - Base Sequence MH - Caveolins/metabolism MH - Cell Line MH - Cell Proliferation/drug effects/genetics MH - Down-Regulation/genetics MH - Fibroblasts/drug effects/*metabolism/*pathology MH - Humans MH - Idiopathic Pulmonary Fibrosis/*genetics/*pathology MH - Intercellular Signaling Peptides and Proteins/pharmacology MH - Male MH - Mice, Inbred C57BL MH - MicroRNAs/genetics/metabolism MH - Middle Aged MH - RNA, Circular/genetics/*metabolism PMC - PMC7374112 COIS- The authors declare that they have no conflict of interest. EDAT- 2020/07/23 06:00 MHDA- 2021/03/25 06:00 PMCR- 2020/07/21 CRDT- 2020/07/23 06:00 PHST- 2019/12/02 00:00 [received] PHST- 2020/07/03 00:00 [accepted] PHST- 2020/07/01 00:00 [revised] PHST- 2020/07/23 06:00 [entrez] PHST- 2020/07/23 06:00 [pubmed] PHST- 2021/03/25 06:00 [medline] PHST- 2020/07/21 00:00 [pmc-release] AID - 10.1038/s41419-020-02747-9 [pii] AID - 2747 [pii] AID - 10.1038/s41419-020-02747-9 [doi] PST - epublish SO - Cell Death Dis. 2020 Jul 21;11(7):553. doi: 10.1038/s41419-020-02747-9.